Clinical trials of Jupiter looks at the treatment of ovarian cancer

JUPITER - Jupiter Medical Center is enrolling in a clinical trial patients to examine an experimental treatment for women with cancer of the ovary Platinum sensitive which has recurred.

The trial is sponsored by Morphotek and focuses on a monoclonal antibody experimental - farletuzumab - which may well block the protein involved in the development of the tumor cells in Platinum-sensitive ovarian cancer.

Researchers are eager to discover if a new drug may extend the duration of the second restoration gals who have relapsed after six months of their latest method of treatment.

For many more facts, contact (561) 745-5768.

This entry was published on Wednesday, March 16, 2011 at 12: 38 pm and is filed under treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or a trackback from your own site.